A periadventitial sirolimus-releasing mesh decreased intimal hyperplasia in a rabbit model

Physiological Research

Volumn 60, Issue 3, 2011, Pages 585-588

  Skalsky I ^a   Filova E ^b,c   Szarszoi O ^a,c   Parzek M ^b,c   Lytvynets, A ^b   Maluskova J ^a   Lodererova A ^a   Brynda, E ^d   Lisa V ^b   Burdikova Z ^b   Capek M ^b   Pirk, J ^a,c   Bacakova L ^b,c  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^c Centre for Experimental Cardiovascular Research   (Czech Republic)

^d INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Czech Republic)

Author keywords

Controlled drug release; Intimal hyperplasia; Perivascular mesh; Rapamycin; Stenosis

Indexed keywords

EID: 79960939082     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: 10.33549/physiolres.932106     Document Type: Article

References (11)

1. COLOMBO A, IAKOVOU I, Drug-eluting stents: the new gold standard for percutaneous coronary revascularisation. Eur Heart J 25: 895-897, 2004.
2. EN 12332-1 (804629) Rubber- or plastics-coated fabrics. Determination of bursting strength. Steel ball method British-Adopted European Standard/15-Feb-1999/8 pages.
3. FILOVÁ E, PAŘÍZEK M, OLŠOVSKÁ J, KAMENÍK Z, BRYNDA E, RIEDEL T, VANDROVCOVÁ M, LISÁ V, MACHOVÁ L, SKALSKÝ I, SZÁRSZOI O, SUCHÝ T, BAČÁKOVÁ L, Perivascular sirolimus-delivery system. Int J Pharm 404: 94-101, 2011.
4. JEREMY JY, BULBULIA R, JOHNSON JL, GADSDON P, VIJAYAN V, SHUKLA N, SMITH FCT, ANGELINI GD, A bioabsorbable (polyglactin), nonrestrictive, external sheath inhibits porcine saphenous vein graft thickening. J Thorac Cardiovasc Surg 127: 1766-1772, 2004.
5. JIANG Z, WU L, MILLER BL, GOLDMAN DR, FERNANDEZ CM, ABOUHAMZE ZS, OZAKI CK, BERCELI SA, A novel vein graft model: adaptation to differential flow environments. Am J Physiol Heart Circ Physiol 286: H240-H245, 2004.
6. KREJCA M, SKARYSZ J, SZMAGALA P, PLEWKA D, NOWACZYK G, PLEWKA A, BOCHENEK A, A new outside stent - does it prevent vein graft intimal proliferation? Eur J Cardiothorac Surg 22: 898-903, 2002.
7. LIUZZO JP, AMBROSE JA, COPPOLA JT, Sirolimus- and taxol-eluting stents differ towards intimal hyperplasia and re-endothelialization. J Invasive Cardiol 17: 497-502, 2005.
8. MOTWANI JG, TOPOL EJ, Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 97: 916-931, 1998.
9. OWEN SC, LI H, SANDERS WG, CHEUNG AK, TERRY CM, Correlation of tissue drug concentrations with in vivo magnetic resonance images of polymer drug depot around arteriovenous graft. J Control Release 146: 23-30, 2010.
10. SCHACHNER T, ZOU Y, OBERHUBER A, TZANKOV A, MAIRINGER T, LAUFER G, BONATTI JO, Local application of rapamycin inhibits neointimal hyperplasia in experimental vein grafts. Ann Thorac Surg 77: 1580-1585, 2004.
11. SUZUKI T, KOPIA G, HAYASHI S, BAILEY LR, LLANOS G, WILENSKY R, KLUGHERZ BD, PAPANDREOU G, NARAYAN P, LEON MB, YEUNG AC, TIO F, TSAO PS, FALOTICO R, CARTER AJ, Stent-based delivery of sirolimus reduced neointimal formation in a porcine coronary model. Circulation 104: 1188-1193, 2001.